The prostaglandin E2 receptor, EP2, regulates survivin expression via an EGFR/STAT3 pathway in UVB-exposed mouse skin

Prostaglandin E Receptor EP1 Suppresses Breast Cancer Metastasis and Is Linked to Survival Differences and Cancer Disparities

(2010) Xinrong Ma et al.   MOLECULAR CANCER RESEARCH

The prostaglandin receptor EP2 activates multiple signaling pathways and  -arrestin1 complex formation during mouse skin papilloma development

(2009) K.-S. Chun et al.   CARCINOGENESIS

Celecoxib reduces the effects of acute and chronic UVB exposure in mice treated with therapeutically relevant immunosuppressive drugs

(2009) Brian C. Wulff et al.   INTERNATIONAL JOURNAL OF CANCER

Co-expression of survivin, c-erbB2, and cyclooxygenase-2 (COX-2): prognostic value and survival of endometrial cancer patients

(2009) Maria Lambropoulou et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Prostaglandin E2 upregulates survivin expression via the EP1 receptor in hepatocellular carcinoma cells

(2009) Xiao-Ming Bai et al.   LIFE SCIENCES

Cigarette smoke and increased COX-2 and survivin levels in exhaled breath condensate of lung cancer patients: How hot is the link?

(2009) Giovanna E. Carpagnano et al.   LUNG CANCER

Selective Inhibition of Prostaglandin E2 Receptors EP2 and EP4 Induces Apoptosis of Human Endometriotic Cells through Suppression of ERK1/2, AKT, NFκB, and β-Catenin Pathways and Activation of Intrinsic Apoptotic Mechanisms

(2009) Sakhila K. Banu et al.   MOLECULAR ENDOCRINOLOGY

Upregulation of survivin by leptin/STAT3 signaling in MCF-7 cells

(2007) Haiping Jiang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS